Amendment No. 4 to the Pfizer Inc. Executive Severance Plan
Contract Categories:
Human Resources
›
Severance Agreements
Summary
This amendment updates the Pfizer Inc. Executive Severance Plan by changing the eligibility dates for certain executive severance benefits. It specifies that eligible employees must have an Official Notification Date between December 21, 2018, and April 21, 2023, or a Date of Termination on or before June 30, 2023. The amendment clarifies the definition of "Official Notification Date" as the start of the employee's Notice Period. The parties involved are Pfizer Inc. and its eligible executive employees.
EX-10.39 6 pfe-exh1039x12312022x10k.htm EX-10.39 Document
EXHIBIT 10.39
Amendment No. 4 to the
Pfizer Inc. Executive Severance Plan
* * *
(New material underlined; deletions crossed out)
Section 2.1(c) of Appendix A of the Pfizer Inc. Executive Severance Plan is amended to read as follows:
(c) His or her Official Notification Date is on or after December 21, 2018 and on or before April 21, 2023 October 21, 2022 or his Date of Termination is on or before June 30, 2023 December 19, 2022. “Official Notification Date” means the date an eligible employee’s Notice Period begins.
